Topical ophthalmic administration of the antiangiogenic peptide VIAN-c4551 protects against experimental diabetic macular edema. - Adán-Castro, Elva; Zamora, Magdalena; Granados-Carrasco, Daniela; Siqueiros-Márquez, Lourdes; García-Rodrigo, Jose F.; Macias, Fernando; Bertsch, Thomas; Triebel, Jakob; Arnold, Edith; Martínez de la Escalera, Gonzalo; Robles, Juan Pablo; Clapp, Carmen (Scientific Reports, 2025)